Prolactin effects on the pathogenesis of diabetes mellitus
European Journal of Clinical Investigation · 2024-06 · 54 (6)
DOI: 10.1111/eci.14190 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift European Journal of Clinical Investigation, online erschienen am 12.03.2024. Verfasst von Roberta Scairati und 5 weiteren Autor:innen. Beteiligte Einrichtung: Dipartimento di Medicina Clinica e Chirurgia, Sezione di Endocrinologia, Diabetologia, Andrologia e Nutrizione, Università Federico II di Napoli, Nap…. Hauptthemen laut MEDLINE: Prolactin, Diabetes, Gestational, Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 111 Literaturangaben.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Background
Prolactin (PRL) is a pituitary hormone promoting lactation in response to the suckling reflex. Beyond its well‐known effects, novel tissue‐specific and metabolic functions of PRL are emerging.
Aims
To dissect PRL as a critical mediator of whole‐body gluco‐insulinemic sensitivity.
Methods
PubMed‐based search with the following terms ‘prolactin’, ‘glucose metabolism’, ‘type 2 diabetes mellitus’, ‘type 1 diabetes mellitus’, ‘gestational diabetes mellitus’ was performed.
Discussion
The identification of the PRL‐glucose metabolism network poses the basis for unprecedented avenues of research in the pathogenesis of diabetes mellitus type 1 or 2, as well as of gestational diabetes. In this regard, it is of timely relevance to define properly the homeostatic PRL serum levels since glucose metabolism could be influenced by the circulating amount of the hormone.
Results
This review underscores the basic mechanisms of regulation of pancreatic β‐cell functions by PRL and provides a revision of articles which have investigated the connection between PRL unbalancing and diabetes mellitus. Future studies are needed to elucidate the burden and the role of PRL in the regulation of glucose metabolism and determine the specific PRL threshold that may impact the management of diabetes.
Conclusion
A careful evaluation and context‐driven interpretation of PRL levels (e.g., pregnancy, PRL‐secreting pituitary adenomas, drug‐related hyper‐ and hypoprolactinemia) could be critical for the correct screening and management of glucometabolic disorders, such as type 1 or 2 as well as gestational diabetes mellitus.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Dipartimento di Medicina Clinica e Chirurgia, Sezione di Endocrinologia, Diabetologia, Andrologia e Nutrizione, Università Federico II di Napoli, Naples, Italy.
- UNESCO Chair for Health Education and Sustainable Development, University Federico II, Naples, Italy.
ORCID-Profile: Annamaria Colao
Zitieren
APA
Scairati, R., Auriemma, R. S., Del Vecchio, G., Di Meglio, S., Pivonello, R., & Colao, A. (2024). Prolactin effects on the pathogenesis of diabetes mellitus. European Journal of Clinical Investigation, 54(6). https://doi.org/10.1111/eci.14190
Vancouver
Scairati R, Auriemma RS, Del Vecchio G, Di Meglio S, Pivonello R, Colao A. Prolactin effects on the pathogenesis of diabetes mellitus. European Journal of Clinical Investigation. 2024;54(6). doi:10.1111/eci.14190
BibTeX
@article{Scairati2024,
author = {Scairati, Roberta and Auriemma, Renata Simona and Del Vecchio, Guendalina and Di Meglio, Sara and Pivonello, Rosario and Colao, Annamaria},
title = {Prolactin effects on the pathogenesis of diabetes mellitus},
journal = {European Journal of Clinical Investigation},
year = {2024},
volume = {54},
number = {6},
doi = {10.1111/eci.14190}
}
EUVIMED